arrow
A

Agnies M. van Eeghen

university hospital leuven
H指数:24
被引数:2,325

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Closing the Gap to Interventions for Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): Protocol fora Longitudinal Study of TAND Severity, Predictors, and Caregiver Well-Being (TANDem-2)

缩小结节性硬化症相关神经精神障碍(TAND)干预差距:TAND严重程度、预测因素和照护者福祉的纵向研究方案(TANDem-2)

2026-05-080
PRE
Correction: A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome

更正:FMRP的KH0结构域中的一个错义变异在一名具有脆性X综合征临床特征的患者中下调了该蛋白。

2026-03-310
PRE
Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury

血清NfL、GFAP和p-tau217在药物难治性癫痫及智力障碍成人中的研究:持续神经损伤的标志

2026-03-300
OAAI
Potential benefits of l-serine in children with GRIN2B loss-of-function variants: Randomized n-of-1 trials

L-丝氨酸在具有GRIN2B功能丧失性变异的儿童中的潜在益处:随机n-of-1试验

2025-10-300
PRE
A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome

FMRP的KH0结构域中的一个错义变异导致该蛋白在具有脆性X综合征临床特征的患者中表达下调。

2025-10-210
PRE
Do we care? Reporting of genetic diagnoses in multidisciplinary intellectual disability care: a retrospective chart review

我们在乎吗?多学科智力残疾护理中遗传诊断的报告: 回顾性图表回顾

2024-09-160
OAAI
Dementia in Rare Genetic Neurodevelopmental Disorders

罕见的遗传性神经发育障碍中的痴呆

2024-06-111
OAAI
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
2024-01-044
OAAI